Lung Fung Group Holdings Limited

Research Lung Fung Group Holdings Limited (2290.HK) on Bullrun: market cap HKD 2.09B, P/E 7.7. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 2.09B; P/E is 7.7.

Peer valuation comparison

Latest P/E is 7.72x versus a Consumer Cyclical sector median of 15.9x (51.4% below).

Latest P/E is 7.72x versus a Hong Kong median of 10.3x (25.1% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025HKD 2.46BHKD 170.43MHKD 1.41B31.6%0.34HKD 61.18MHKD 1.02BHKD 44.38M
FY2024HKD 2.02BHKD 144.54MHKD 1.21B29.3%0.29HKD 61.41MHKD 1.01BHKD 129.52M
FY2023HKD 1.09B-HKD 27.14MHKD 705.42M24.9%-0.05HKD 43.14MHKD 1.02B-HKD 15.05M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 2.09B7.7n/a153

Dividend history

Latest trailing dividend snapshot: annual dividend/share 153 HKD.

About Lung Fung Group Holdings Limited

Lung Fung Group Holdings Limited, through its subsidiaries, sells beauty, health and pharmaceutical products. The company offers Chinese and western medicines, health products, medical supplies, beauty and skin care, cosmetics, maternal and infant products, food, and personal care, and household daily necessities. It is also involved in advertising and promotion agencies; operation of retail stores; and wholesaling activities. The company sells its products through retail stores and online sale platforms.

Related stock research

Other Consumer Cyclical stocks

Frequently asked questions

What is Lung Fung Group Holdings Limited's market cap?

Lung Fung Group Holdings Limited's market capitalization is HKD 2.09B.

What is Lung Fung Group Holdings Limited's P/E ratio?

Lung Fung Group Holdings Limited's price-to-earnings (P/E) ratio is 7.7.

What does Lung Fung Group Holdings Limited do?

Lung Fung Group Holdings Limited, through its subsidiaries, sells beauty, health and pharmaceutical products. The company offers Chinese and western medicines, health products, medical supplies, beauty and skin care, cosmetics, maternal and infant products, food, and personal care, and household daily necessities. It is also involved in advertising and promotion agencies; operation of retail stores; and wholesaling activities. The company sells its products through retail stores and online sale platforms. The company was founded in 1992 and is headquartered in Fanling, Hong Kong.